Technology Platform


News Center

Gmax Appoints Mr. Bing Zhu as CFO

Gmax, a clinical stage biopharmaceutical company focusing on G-protein coupled receptors (GPCRs) therapeutic antibody and Bibody development, today announced the appointment of Mr. Bing Zhu...

Gmax R&D Team is Selected as “Leading Innovation Team”, Zhejiang Province

The Gmax R&D Team on “Diabetes, obesity and pulmonary hypertension” is recently selected as the “Leading Innovation Team of the Zhejiang Province, 2017”.